| 注册
首页|期刊导航|临床与病理杂志|埃克替尼对非小细胞肺癌EGFR 18外显子突变的临床疗效

埃克替尼对非小细胞肺癌EGFR 18外显子突变的临床疗效

黄韵坚 林贤东 许春伟 陈刚 陈燕坪 庄武 黄章洲 朱有才 杜开齐 方美玉 王晓江 师怡

临床与病理杂志2017,Vol.37Issue(4):729-734,6.
临床与病理杂志2017,Vol.37Issue(4):729-734,6.DOI:10.3978/j.issn.2095-6959.2017.04.014

埃克替尼对非小细胞肺癌EGFR 18外显子突变的临床疗效

Clinical efficacy of icotinib in patients with advanced non-small cell lung cancer harboring EGFR exon 18 mutations

黄韵坚 1林贤东 2许春伟 2陈刚 2陈燕坪 2庄武 1黄章洲 1朱有才 3杜开齐 3方美玉 4王晓江 2师怡2

作者信息

  • 1. 福建医科大学附属福建省肿瘤医院胸部肿瘤内科,福州350014
  • 2. 福建医科大学附属福建省肿瘤医院病理科,福州350014
  • 3. 浙江省荣军医院胸部疾病中心,浙江嘉兴314000
  • 4. 浙江省肿瘤医院综合肿瘤内科,杭州310022
  • 折叠

摘要

Abstract

Objective:To investigate the efficacy oficotinib in patients with non-small cell lung cancer (NSCLC) that carrying G719X/E709X/G724S in EGFR exon 18.Methods:We retrospectively analysed 24 cases of EGFR 18 exon rare mutation NSCLC patients until the progress of the disease or the emergence of the side effects and clinical efficacy was observed after months followed-up.Results:Twenty-four patients with G719X/E709X/G724S mutations were enrolled.Mutations including G719X,E709X and G724S mutations were observed in 19,3 and 2 patients,respectively.In total,the median progression-free survival (PFS) were 3.1 months,respectively.Patients with G724S mutation manifested the longest median PFS (3.5 months),followed by those with E709X (3.1 months) and G719X (2.8 months).Patients with complex mutations showed a better PFS than those with single mutations (G719X mutations 3.3 months vs.2.6 months,P=0.029;E709X 7.2 months vs.2.7 months,P=0.225).Conclusion:Icotinib is less effective in patients with exon 18 uncommon mutations than in those with common mutations.Patients with complex mutations benefited more from icotinib than those with single mutations.

关键词

非小细胞肺癌/埃克替尼/18外显子

Key words

non-small cell lung cancer/icotinib/exon 18

引用本文复制引用

黄韵坚,林贤东,许春伟,陈刚,陈燕坪,庄武,黄章洲,朱有才,杜开齐,方美玉,王晓江,师怡..埃克替尼对非小细胞肺癌EGFR 18外显子突变的临床疗效[J].临床与病理杂志,2017,37(4):729-734,6.

基金项目

国家临床重点专科建设项目(2013) (2013)

福建省科技厅引导性项目(2016Y0019) (2016Y0019)

福建省科技厅引导性项目(2015Y0011) (2015Y0011)

浙江省卫生科研计划基金(2013KYB051) (2013KYB051)

浙江省中医药局科研基金(2013ZQ005) (2013ZQ005)

浙江省科技厅公益类科研计划(2015C33194).This work was supported by National Clinical Key Specialty Construction Program (2013) (2015C33194)

Leading Project Foundation of Science Department of Fujian Province (2016Y0019) (2016Y0019)

Leading Project Foundation of Science Department of Fujian Province (2015Y0011) (2015Y0011)

Medical Scientific Research Foundation of Zhejiang Province (2013KYB051) (2013KYB051)

Zhejiang Administration of Traditional Chinese Medicine Foundation (2013ZQ005) (2013ZQ005)

The Science and Technology Planning Project of Zhejiang Province (2015C33194),China. (2015C33194)

临床与病理杂志

OACSTPCD

1673-2588

访问量0
|
下载量0
段落导航相关论文